Standards; Isotopic Labeled Analogues; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; Carbohydrates and Oligosaccharides;
應(yīng)用:
Empagliflozin-d8 is a labelled form of Empagliflozin (E521510), which is a novel, potent and selective SGLT-2 inhibitor. It improves glycaemic control syndrome in diabetic rats.
?您的位置：
